Pilot study investigates the role of Treg and pDCs in drug rash conditions, indicating their impact on inflammation.
Treg cells and pDCs play a role in DRESS/DIHS and MPE pathogenesis, evidenced by the fluctuation in their percentages at each stage of both conditions. However, increased circulating Treg cells may crucially mitigate inflammation in both conditions.
No takes yet. Share an insight, caveat, or question.
Julanon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: